Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)

NCT00844142 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Moderate to Severe Active Axial Spondyloarthritis

Interventions

DRUG: Etanercept 25mg
DRUG: Sulfasalazine

Sponsor

Charite University, Berlin, Germany

Collaborators

[object Object]